Land: Sydafrika
Språk: engelska
Källa: South African Health Products Regulatory Authority (SAHPRA)
Lennon
A-LENNON AMOXYCILLIN 250 mg CAPSULES A-LENNON AMOXYCILLIN 500 mg CAPSULES SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): A-LENNON AMOXYCILLIN 250 mg CAPSULES A-LENNON AMOXYCILLIN 500 mg CAPSULES COMPOSITION: A-Lennon Amoxycillin 250 mg Capsules: Each hard gelatin capsule contains Amoxycillin Trihydrate equivalent to 250 mg Amoxycillin . A-Lennon Amoxycillin 500 mg Capsules: Each hard gelatin capsule contains Amoxycillin Trihydrate equivalent to 500 mg Amoxycillin. PHARMACOLOGICAL CLASSIFICATION: A 20.1.2 Penicillins PHARMACOLOGICAL ACTION: A-Lennon Amoxycillin Capsules is a semisynthetic aminopenicillin with an in vitro bactericidal action against a broad spectrum of gram-positive and gram-negative pathogens. The presence of the enzyme penicillinase has a major influence on the degree and extent of its activity against organisms. Being acid stable it is well absorbed when given orally. The in vitro antibacterial spectrum of A-Lennon Amoxycillin Capsules is as follows (care must however be exercised when extrapolating this to the clinical situation): A-Lennon Amoxycillin Capsules is particularly active against the following organisms: Gram-positive organisms: Streptococcus pneumoniae*, Streptococcus faecalis* (enterococci), Streptococcus agalactiae (group B), penicillin- sensitive Neisseria gonorrhoeae, Listeria monocytogenes. A-Lennon Amoxycillin Capsules is also active against the following organisms: Gram-positive organisms: Staphylococcus aureus* (penilcillin sensitive), Streptococcus pyogenes, Streptococcus viridans*, Streptococcus bovis, Neiserria meningitidis (except the carrier state), Bacillus anthracis*, Corynebacterium species*, Clostridium species*; A-Lennon Amoxycillin Capsules also has in vitro activity against the following gram-negative organisms (these organisms may produce beta-lactamase Läs hela dokumentet